ASP Isotopes Inc.
Company Information
Industry Miscellaneous Chemical Products
SIC Code 2890
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201
Mailing Address 2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201
Phone 202-756-2245
Fiscal Year End 1231
EIN 872618235
Financial Overview
FY2024
$94.35M
Total Assets
$47.90M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 9, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
Material Events
8-K Other January 29, 2026
High Impact
- Plant now processes approximately 60% more gas thanks to upgrades and new wells.
- Achieved an approximately 80% drilling success rate (15 of 18 wells hit gas) since ASPI's involvement.
8-K Acquisition January 12, 2026
High Impact
- Official closure of the major acquisition of Renergen Limited, expanding into helium and natural gas projects.
- Strategic diversification of ASP Isotopes' business beyond isotopes into energy and specialized materials.
8-K Acquisition January 7, 2026
High Impact
- ASP Isotopes Inc. completed the acquisition of Renergen Limited, making Renergen a fully owned subsidiary.
- ASP Isotopes issued approximately 14.27 million of its shares to Renergen's previous owners as consideration.
8-K Acquisition December 18, 2025
High Impact
- ASP Isotopes Inc. is acquiring Renergen Limited, significantly expanding its operations and market reach.
- Renergen shareholders will receive 0.09196 new ASP Isotopes shares for every Renergen share they own.
8-K Acquisition December 17, 2025
High Impact
- ASP Isotopes Inc. has received all necessary regulatory approvals and clearances to acquire Renergen Limited.
- This clears a major hurdle for the acquisition, which is a crucial step in ASP Isotopes Inc.'s strategic growth plan.
8-K Leadership Change December 8, 2025
High Impact
- Paul Mann, founder and Executive Chairman, is returning to his role as Chief Executive Officer (CEO) of ASP Isotopes Inc.
- Robert Ainscow, who served as Interim CEO, will return to his previous position as Chief Operating Officer (COO).
Insider Trading
STRONG SELL 3 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2890)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.